1Kikuchi M.Lymphadenitis shouing focal reticulum cell hyperplasia with nuclear debris and phagocytosis.Nippon Ketsueki Gakkai Zasshi,1972,35(11):379-380.
2Fujimato Y,Kozima Y,Yamaguchi K.Cervical subacute nicrotizing lymphadenitis:A new clinicopathological entity.Naika,1972,376(4):247-253.
3Thongsuksai P,Kayasut K:Histiocytic necrotizing lymphadecitis.J Med Assoc Thai,1999,82(8):812-818.
4Kubota M,Tsukamoto R,Kurukawa K,et al.Elevated serum interferon gamma and interleukin-6 in patients with necrotizing lymphadenitis.Br J Hematol,1996,95(4):613-615.
5Takakuwa T,Ohnuma S,Koike J,et al.Involvement of cell-mediated killing in apoptosis in histiocytic necrotizing lymphadenitis (KikuchiFrjimato Disease).Histopathology,1996,28(1):41-48.
6Ura H,Yamada N,Torii H,et al.Histiocytic necrotizing lymphadenitis (Kikuchi's disease):The necrotic apperarance of the lymph vode cells is caused by apoptosis.J Dermatol,1999,26(6):385-389.
7Kruger GR,Huetter ML,Rojo J,et al.Human herpes viruses HHV-4 (EBV) and HHV-6 in Hodkin's and Kikuchi's diseases and their relation to proliferation and apoptosis.Antacancer Res,2001,21 (3C):2155-2161.
9Stephan LJ,Jeannoel P,Chanoz J,et al.Epstein Barr virus associated Kikuchi Disease in two children.J Ped Hematol Oncol,2001,23 (4):240 -243.
10Iguchi H,Sunami K,Yamane H,et al.Apoptotic cell death in Kikuchi's disease:A TEM study.Acta Otolaryngol Suppl,1998,538:250-253.
二级参考文献16
1[11]Tsai ST, Jin YT and Su IJ. Expression of EBER1 in primary and metastatic NPC tissues using in situ hybridization. A correlation with WHO histologic subtypes. Cancer. 1996 ; 77: 231- 236.
2[12]Vakkala M, Paakko P and Soini Y. Expression of caspase 3,6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion. Br J Cancer.1999;81:592- 599.
3[13]Hu LF, Chen F, Zhen QF, et al. Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinoma. Eur J Cancer. 1995; 31A: 658- 661.
4[14]Zhang XN, Hu LF, Chen F,et al. EBV LMP1 inhibits TNF mediated apoptosis in epithelial cell lines Rhek-1 and HeLA through induction of zinc finger protein A20. Virology, 2001 ;in publication.
5[15]Thornberry NA ,Lazebnik Y. Caspases : enemies within.(Review). Science. 1998 ; 281:1312- 1316.
6[16]Hoshi T, Sasano H, Kato K,et al. Immunohistochemistry of caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis. Anticancer Res.1998 ; 18:4347- 4353.
7[1]Hu LF, Troyanovasky B, Zhang XN, et al. Differences in the immunogenicity of latent membrane protein 1 (LMP1)encoded by Epstein-Barr virus genomes derived from LMP1-positie and-negative nasopharyngeal carcinoma.Cancer Res. 2000;60:5111-5116.
8[2]Mosialos G, Birkenbach M, Yalamanchili R, et al. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 1995;80:389-399.
9[3]lzumi KM and Keiff ED. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB. Proc Natl Acad Sci USA. 1997; 94; 12592-12597.
10[4]Huen DS, Henderson SA, Croom-Carter D,et al. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene. 1995 ; 10 : 549- 560.
